Perrigo Fattens European Play, But Remains Main Course On Mylan’s M&A Plate

Acquiring Naturwohl Pharma likely will not put Perrigo out of Mylan’s reach. The generic Rx firm, a takeover target of Teva Pharmaceutical Industries Ltd., has made multiple offers Perrigo has turned down and will ask its shareholders in August to approve a hostile takeover bid.